Treatment of vernal conjunctivitis

Details Treatment of vernal conjunctivitis Treatment of vernal conjunctivitis

1987-02-27

1988-01-26

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Lymphokine

424101, A61K 39395

Patent

active

047216166

ABSTRACT:
Vernal conjunctivitis is treated by administration of an intravenously injectable form of a polyvalent, intact immunoglobulin (IgG).

REFERENCES:
patent: 3903262 (1975-09-01), Pappenhagen et al.
patent: 4168303 (1979-09-01), Nishida et al.
Abernathy, Rosalind S., et al. Pediatrics, pp. 980-993, (Jun. 1958).
Thomas, Orville C., et al. Southern Medical Journal, vol. 57, pp. 498-504 (May, 1964).
Hilman, Bettina C., et al. JAMA, vol. 207, No. 5, pp. 902-906 (Feb. 1969).
Redner, Bernard, et al., JAMA, vol. 185, No. 9, pp. 692-695 (Aug. 1963).
Chem. Abs. vol. 93, Abstract No. 210233z, 1980.
J. Ring et al in Munch. Med. Wochenschrift 1983, 125, 289-92.
Clinical Opthamology vol. 4 (1978) by M. Allansmith.
Chapter 7, "Ocular Diseases with Immunologie Features" in Allergy and Immunology of the Eye (1979) by M. Friedlaender.

Affiliated with

Also associated with

Rating

Treatment of vernal conjunctivitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of vernal conjunctivitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of vernal conjunctivitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1467455